مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: ERK5 activation is essential for osteoclast differentiation.
Normal view MARC view ISBD view

ERK5 activation is essential for osteoclast differentiation. [electronic resource]

By:
  • Amano, Shigeru
Contributor(s):
  • Chang, Yu-Tzu
  • Fukui, Yasuhisa
Producer: 20160531Description: e0125054 p. digitalISSN:
  • 1932-6203
Subject(s):
  • Acid Phosphatase -- metabolism
  • Aniline Compounds -- pharmacology
  • Animals
  • Benzodiazepinones -- pharmacology
  • Bone Marrow Cells -- cytology
  • Cell Differentiation -- drug effects
  • Cell Line -- drug effects
  • Enzyme Activation -- drug effects
  • Humans
  • Indoles -- pharmacology
  • Isoenzymes -- metabolism
  • MAP Kinase Kinase 5 -- antagonists & inhibitors
  • Macrophage Colony-Stimulating Factor -- pharmacology
  • Male
  • Mice, Inbred Strains
  • Mitogen-Activated Protein Kinase 7 -- antagonists & inhibitors
  • Osteoclasts -- cytology
  • Phosphorylation -- drug effects
  • Protein Kinase Inhibitors -- pharmacology
  • Proto-Oncogene Proteins c-fos -- genetics
  • RANK Ligand -- metabolism
  • Tartrate-Resistant Acid Phosphatase
Online resources:
  • Available from publisher's website
In: PloS one vol. 10
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 1 Multiple sclerosis: neuroimmunologic puzzle.
    by Barna, B P
  • 2 Autoimmune inner ear disease: fact or fantasy?
    by Hughes, G B
  • 3 Immunological activity of regional lymph nodes in tumor-bearing mice.
    by Barna, B P
  • 4 Autoimmunity and otologic disease: clinical and experimental aspects.
    by Barna, B P
  • 5 Autoimmune inner ear disease--a real entity?
    by Barna, B P
  • 6 Serum interleukin 2 and soluble interleukin 2 receptor in patients with multiple sclerosis who are experiencing severe fatigue.
    by Rudick, R A
  • 7 Immune mechanisms in beryllium lung disease.
    by Deodhar, S D
  • 8 Immunology, tumor markers, and breast cancer.
    by Barna, B P
  • 9 Macrophage activation. Potential for cancer therapy.
    by Deodhar, S D
  • 10 Activation of human monocyte tumoricidal activity by C-reactive protein.
    by Barna, B P
  • 11 Tumor-enhancing effects of cimetidine.
    by Barna, B P
  • 12 Lymphocyte transformation and radioallergosorbent tests in drug hypersensitivity.
    by Barna, B P
  • 13 Astrocyte interactions with immune modifiers: a possible role for astrocytes in the immunopathogenesis of multiple sclerosis (MS).
    by Barna, B P
  • 14 Immunologic studies of experimental beryllium lung disease in the guinea pig.
    by Barna, B P
  • 15 Granulomatous disease associated with pulmonary deposition of titanium.
    by Redline, S
  • 16 Modulation of proliferation and antigen expression of a cloned human glioblastoma by interleukin-4 alone and in combination with tumor necrosis factor-alpha and/or interferon-gamma.
    by Iwasaki, K
  • 17 Modulation of human alveolar macrophage tumoricidal activity by recombinant macrophage colony-stimulating factor.
    by Thomassen, M J
  • 18 Interleukin-4 down-regulates adult human astrocyte DNA synthesis and proliferation.
    by Estes, M L
  • 19 Involvement of interleukin-1beta-converting enzyme in apoptosis of irradiated retinoblastomas.
    by Kondo, Y
  • 20 Autoimmunity in otology.
    by Hughes, G B
Close

ERK5 activation is essential for osteoclast differentiation.

APA

Amano S., Chang Y. & Fukui Y. (20160531). ERK5 activation is essential for osteoclast differentiation. : PloS one.

Chicago

Amano Shigeru, Chang Yu-Tzu and Fukui Yasuhisa. 20160531. ERK5 activation is essential for osteoclast differentiation. : PloS one.

Harvard

Amano S., Chang Y. and Fukui Y. (20160531). ERK5 activation is essential for osteoclast differentiation. : PloS one.

MLA

Amano Shigeru, Chang Yu-Tzu and Fukui Yasuhisa. ERK5 activation is essential for osteoclast differentiation. : PloS one. 20160531.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site